Clinical Trials Browser

Phase 2 × Metastatic Castration-resistant Prostate Cancer × darolutamide × Clear all

NCT06401980 2025-08-14

Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Phase 2 Recruiting

Metastatic Castration-resistant Prostate Cancer

NCT05762536 2024-06-27

DAROTAXEL

Phase 2 Recruiting

Metastatic Castration-resistant Prostate Cancer